The effects of ursodeoxycholic acid on cardiometabolic risk factors: a systematic review and meta-analysis of randomized controlled trials
Abstract Background Chronic diseases such as obesity, hypertension, and metabolic syndrome are major health concerns worldwide. Ursodeoxycholic acid (UDCA) is a bile acid that is naturally produced in the liver and has been used for the treatment of various liver disorders. In this systematic review...
Saved in:
| Main Authors: | Elaheh Rashidbeygi, Niloufar Rasaei, Mohammad Reza Amini, Marieh Salavatizadeh, Mehdi Mohammadizadeh, Azita Hekmatdoost |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | BMC Cardiovascular Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12872-025-04549-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effects of policosanol supplementation on creatinine: a systematic review and dose–response meta-analysis of randomized controlled trials
by: Mohammad Reza Amini, et al.
Published: (2025-05-01) -
Ursodeoxycholic acid and hepatic diseases
by: G. V. Volynets, et al.
Published: (2021-06-01) -
Rationale, completeness and quality of evidence for the use of ursodeoxycholic acid in neonatal hyperbilirubinemia
by: Olesya V. Zakharova
Published: (2024-05-01) -
Cholelithiasis in Infants: Risk Factors, Management, and the Role of Ursodeoxycholic Acid
by: Sevim Çakar, et al.
Published: (2024-12-01) -
The Impact of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Infants Treated with Photo-therapy: A Single-Blind Randomized Clinical Trial
by: Mohammad Sobhani Shahmirzadi, et al.
Published: (2024-10-01)